A. Grebenyuk

发表

Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results

J. Abrahámová, J. Prausová, V. Vondráček, 2019, Journal of medical imaging and radiation oncology.

Study of the Prooxidant and Antioxidant Activity of Anti-Radiation Agents with LUX-Biosensors

S. Smirnova, S. Abilev, E. Igonina, 2019, Biology Bulletin.

Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer—Single Institution Experience

V. Vondráček, J. Rosina, M. Andrlík, 2021, Cancers.

Ultra-hypofractionated proton radiotherapy in the treatment of low- and intermediate-risk prostate cancer - 5-years outcomes.

T. Doležal, J. Prausová, V. Vondráček, 2021, International journal of radiation oncology, biology, physics.

LOW DOSE BATH FROM IMPT VS. IMXT FOR THE PELVIC AREA WHEN TREATING ADVANCED PROSTATE CANCER.

V. Vondráček, J. Rosina, M. Andrlík, 2019, Radiation protection dosimetry.

The Use of Radioprotective Agents to Prevent Effects Associated with Aging

V. N. Bykov, I. Ushakov, A. Grebenyuk, 2019, Biology Bulletin.

Effects of early therapeutic administration of interleukin-1beta on survival rate and bone marrow haemopoiesis in irradiated mice.

N. Aksenova, A. Grebenyuk, A. Timoshevsky, 2010, Acta medica.

Pencil‐beam scanning proton therapy for the treatment of glomus jugulare tumours

V. Vondráček, J. Rosina, M. Andrlík, 2022, Journal of medical radiation sciences.

Modern Condition and Prospects for the Development of Medicines towards Prevention and Early Treatment of Radiation Damage

A. Grebenyuk, V. Gladkikh, 2019, Biology Bulletin.

Radiomitigators: Classification, Pharmacological Properties, and Application Prospects

V. I. Legeza, I. Drachev, A. Grebenyuk, 2019, Biology Bulletin.